Skip to main content

Primary Care/Hospitalist

RSS  

Articles

  • Guest Column: Substance diversion can and will happen

    Controlled substance diversion is one of those things that every administrator thinks "could never happen to me. I don't have any thieves or drug abusers working here." In my 20 years of being a pharmacist consultant for surgery centers, I've heard that more times than I can count.
  • Quarter of providers report breach in past year

    About one-quarter of healthcare respondents reported that their organization has experienced a security breach in the past year, according to survey results from the Healthcare Information Management and Systems Society (HIMSS) in Chicago.
  • Is your patient dealing with high out-of-pocket?

    More often, outpatient surgery staff members find themselves in the unenviable position of telling patients about out-of-pocket responsibilities running into the thousands of dollars.
  • Don't want a $1 million fine? Pay attention to regulated drugs

    [Editor's note: In this issue of Same-Day Surgery, we put a special focus on compliance with regulated drugs. We've talked with some of the top pharmacy consultants in the country to find out foolproof systems for avoiding diversion and theft. These stories will help you decide where to focus your time and energy, while avoiding liability.]
  • Pediatric Appendicitis

    Abdominal pain is an exceedingly common presentation in the emergency department. Every clinician fears missing the diagnosis of appendicitis. Children are particularly challenging since appendicitis is less common, and the history and physical may be subtle. The diagnostic use of CT is not without its risks and must be balanced against the potential risk of appendicitis in each individual patient. This article provides a comprehensive review of appendicitis in children.
  • Just in: IUDs reduce cervical cancer risk

    To perform the study, researchers designed a pooled analysis of individual data from two large studies by the International Agency for Research on Cancer, an international collaboration on cancer research, and the Institut Català d'Oncologia, a Spanish-based oncology research program.
  • New data emerges on one-size diaphragm

    The contraceptive options for women who cannot use hormonal methods might soon expand if regulatory approval is given to a new single-size diaphragm. Results of a two-year multi-site study of 450 U.S. couples indicate the effectiveness rates of the SILCS single size, contoured diaphragm, now in development, are similar to traditional diaphragms.
  • More condom use by teen males reported

    The safer sex message is reaching adolescents. Results of a new Centers for Disease Control and Prevention (CDC) report shows the percentage of teen males ages 15-19 in the United States who used a condom the first time they had sex increased between 2002 and 2006-2010.
  • OB/GYN Quarterly Update: What healthcare providers should know about detecting thyroidal conditions

    Thyroid dysfunction and disease might present as reproductive compromise including oligomenorrhea, infertility, and miscarriage.
  • FDA schedules review of drospirenone pills

    The Food and Drug Administration (FDA) has scheduled a Dec. 8, 2011, meeting of its Reproductive Health Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee to review the risks and benefits of oral contraceptives containing the progestin drospirenone. The agency is weighing evidence regarding the risk of increased blood clots in users of such pills.